medigraphic.com

2003, Number 4

<< Back Next >>

Rev Fac Med UNAM 2003; 46 (4)

Vitíligo

Jurado SCF

Language: Spanish
References: 30
Page: 152-153
PDF size: 55.07 Kb.


Text Extraction

No abstract


REFERENCES

  1. Morales LM. Vitíligo: Estudio psicosexual comparativo de 30 pacientes. Tesis de Dermatoleprólogo, CDP, México, 1980.

  2. Mosher DB, et al. Vitiligo: Etiology, pathogenesis, diagnosis and treatment. In: Update Dermatology In: General Medicine. Ed. McGraw-Hill. New York. 1999, pp. 794.

  3. Vivot NA. Vitíligo: Etiopatogenia, clínica y tratamiento. Ed. El Ateneo. Buenos Aires. 1954.

  4. Saúl A. Discromías: Vitíligo. En: Lecciones de Dermatología. Ed. Méndez-Cervantes. 14ª. Ed. México, 2001, pp. 474.

  5. Das SK, Mayowder PP, Chakraborty R, et al. Studies on vitiligo. Genet Epidemiol 1985; 2: 71-78.

  6. Hurwitz S. Disorders of pigmentation: Vitiligo. In: Clinical Pediatric Dermatology. ed. W. B. Saunders Co. Philadelphia. 1981: 343-347.

  7. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-666.

  8. Buc M, Busova b, Hegyi E, et al. Vitiligo is associated with HLA-A2 and HLA- Dw7 in the Slovak populations. Folia Biologica 1996; 42: 23-25.

  9. Durham-Pierre DG, Walters CS, Halder RM, et al. Natural killer cell activity against melanocytes in vitiligo. J Am Acad Dermatol 1995; 33: 26-30.

  10. Schallreuter KU, Wood JM, Pittelkow MR, et al. Increased monoamine oxidase activity in the epidermis of patients with vitiligo. Arch Dermatol Res 1996; 188: 14-18.

  11. Ruíz RJ, Campos FJ. Psicoinmunología y dermatología. Dermatología Rev Mex 1984; 28: 148-158.

  12. Rook A, et al. Disorders of skin colour: Vitiligo. In Textbook of Dermatology. Ed. Blackwell Scientific. Londres, 1979: 1421-1424.

  13. Albert DM, et al. Ocular abnormalities occurring with vitiligo. Ophthalmology 1979; 86: 1445-1458.

  14. Cowan CL, Halder RM, et al. Ocular disturbance in vitiligo. J Am Acad Dermatol 1986; 15: 17-24.

  15. Fournier GA, Albert DM. Choroidal halo nevus occurring in a patient with vitiligo. Surg Ophthalmol 1984: 28: 671.

  16. Gass JD. Vitiliginous chorioretinitis. Arch Ophthalmol 1981; 99: 1778-1787.

  17. Lerner AB, et al. Pigment cells of the eyes in people with vitiligo. (letter) N Engl J Med 1977; 296: 232.

  18. Reed WB, et al. Pigmentary disorders in association with congenital deafness. Arch Dermatol 1965; 95: 176.

  19. Thurman TF. Deafness and vitiligo. Birth defects 1976; 12: 315-320.

  20. Halder RM, et. al. Childhood vitíligo. J Am Acad Dermatol 1987; 16: 948-954.

  21. Fernández VR, Sosnowski MI. Vitiligo infantil-patologías asociadas. Rev Arg Derm 1986; 67: 106-112.

  22. Dawber RP, et al. Clinical associations in vitíligo. Postgrad Med J 1970; 46: 276-277.

  23. Peña ML, López CB, García AP. Vitíligo familiar con múltiple afectación autoinmune, asociado a psoriasis. Actas Derm-Sif 1986; 77: 105-108.

  24. El Mofty A, El Mofty M. Vitiligo: A symptom complex. Int J Dermatol 1980; 19: 237-244.

  25. Halder RM, Young CM. Tratamientos nuevos e incipientes para el vitíligo. Dermatol Clinics 2000; 1: 79-89.

  26. Navarro JR, Canales AA, Salado PH, Feria VA. Miniinjerto autólogo de piel e ingestión de 8-metoxipsoraleno en pacientes con vitíligo vulgar. Dermatología Rev Mex 2002; 46: 260-267.

  27. Bose Sk. Modified Thiersh grafting in stable vitiligo. J Dermatol 1996; 23: 363-364.

  28. Falabella R. Repigmentation of stable leukoderma by autologous minigrafting. J Am Acad Dermatol 1983; 9: 514-521.

  29. Falabella R. Repigmentation of stable leukoderma by autologous minigrafting. J Dermatol Surg Oncol 1986; 12: 172-179.

  30. Jurado F. Melagenina: Una alternativa en el tratamiento del vitíligo. Tesis de posgrado en Dermatología, CDP México 1988.




2020     |     www.medigraphic.com